Mineralys Therapeutics Financial Ratios for Analysis 2020-2024 | MLYS

Fifteen years of historical annual and quarterly financial ratios and margins for Mineralys Therapeutics (MLYS).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2023202220212020
23.7613.982.200.29
----
----1.25
----
----
----
----
----
----
----
----
----
----
-29.8157.0184.6695.25
-29.8157.0184.6695.25
-28.57-26.04-174.45-230.55
-29.8157.0184.6695.25
5.86-8.14-4.21-0.66
-2.24-5.66-2.92-0.53
-2.24-5.66-2.92-0.53

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302020-12-31
11.2018.0623.7619.6043.4226.0713.9816.88-----
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-14.14-9.60-10.11-8.62-4.26-4.2617.3615.38-----
-14.14-9.60-10.11-8.62-4.26-4.2617.3615.38-----
-12.88-9.07-9.69-8.20-4.17-4.11-7.93-5.45-----
-14.14-9.60-10.11-8.62-4.26-4.2617.3615.38-----
5.846.615.866.426.987.24-8.14-6.76-----
-1.00-0.43-2.24-1.31-0.83-0.52-5.66-3.67-2.34-1.280.000.000.00
-1.00-0.43-2.24-1.31-0.83-0.52-5.66-3.67-2.34-1.28---